Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 2, 2001, Pages 17-21

  Kinon, B J ^a   Roychowdhury, S M ^a   Milton, D R ^a   Hill, A L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; OLANZAPINE;

ADULT; AGITATION; ARTICLE; BEHAVIOR; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RATING SCALE; REMISSION; SCHIZOPHRENIA; SCORING SYSTEM; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BRIEF PSYCHIATRIC RATING SCALE; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; PIRENZEPINE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0035121481     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pharmacologic treatment strategies in acute schizophrenia
2. Practice guideline for the treatment of patients with schizophrenia
3. Common treatment goals of antipsychotics: Acute treatment
4. The effects of neuroleptics on neuropsychological test results of schizophrenics
5. Neuroleptics: Effects on neuropsychological function in chronic schizophrenic patients
6. New antipsychotics: Classification, efficacy and adverse effects
7. Understanding the mechanism of atypical antipsychotic drags: A review of compounds in use and development
8. The Expert Consensus Guideline Series: Treatment of Schizophrenia 1999
9. Risperidone in the treatment of schizophrenia
10. Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial
11. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial
12. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol
13. Atypical antipsychotics: Are some more atypical than others?
14. Negative symptoms: A path analytic approach to a double-blind placebo- and haloperidol-controlled clinical trial with olanzapine
15. Depressive signs and symptoms in schizophrenia: A prospective blinded trial of olanzapine and haloperidol
16. Olanzapine versus placebo and haloperidol: Quality of life and efficacy results of the North American double-blind trial
17. Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses
18. Antipsychotic drugs and relapse prevention
19. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone or haloperidol
20. Safety of olanzapine
21. Superior efficacy of olanzapine over haloperidol: Analysis of patients with schizophrenia from a multicenter international trial
22. New developments in dopamine and schizophrenia
23. Coarse, jerky foot tremor: Tremographic investigation of an objective sign of acute akathisia
24. Akathisia variants and tardive dyskinesia
25. Clinical characteristics and predisposing factors in acute drug-induced akathisia